Research map: Post-translational modifications in extracellular microvesicles from plasma of Rheumatoid Arthritis patients following anti-TNFα therapy
Back to the article
Papers in this map
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
· Josef S Smolen · 2017 · 7417 citations · Cited by this paper
CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A
· 2026 · Related
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
· Daniel Aletaha · 2010 · 5010 citations · Cited by this paper
Docosahexaenoic acid mitigates experimental autoimmune prostatitis by inhibiting Th17 cell differentiation via the PPARγ/NF-κB/IL-17A pathway
· 2025 · Related
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
· Daniel Aletaha · 2005 · 1092 citations · Cited by this paper
BAFF-R Expression as a Potential Biomarker Associated with COVID-19 Vaccine Non-Responsiveness in Antibody-Deficient Patients
· 2025 · Related
The role of JAK/STAT signaling pathway and its inhibitors in diseases
· Ping Xin · 2020 · 1010 citations · Cited by this paper
PSMB8 stratifies therapy response in eosinophilic esophagitis
· 2026 · Related
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
· Ellen M. Gravallese · 2023 · 771 citations · Cited by this paper
Vitamin A deficiency enhances susceptibility to experimental autoimmune pancreatitis through activation of CD4+ T cells expressing CXCR3 and secreting CCL25
· 2025 · Related
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage
· Jing Shi · 2011 · 594 citations · Cited by this paper
Discovery and Phase 1 study of a novel monoclonal antibody against human IL-1β for the treatment of IL-1β-mediated diseases
· 2025 · Related
Therapeutic advances in rheumatoid arthritis
· Philip M. Brown · 2024 · 307 citations · Cited by this paper
Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency
· 2026 · Related
Extracellular vesicles: mediators of intercellular communication in tissue injury and disease
· Greg Berumen Sánchez · 2021 · 290 citations · Cited by this paper
The pathophysiology of hemophagocytic lympho-histiocytosis (HLH) syndrome and insights from animal models
· 2025 · Related
Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift
· Kevin D. Deane · 2020 · 260 citations · Cited by this paper
PD-1 engagement and circulating Th17 effector activity during secukinumab treatment in plaque psoriasis
· 2026 · Related
The Rheumatoid Arthritis-Associated Citrullinome
· Ronak R. Tilvawala · 2018 · 209 citations · Cited by this paper
Immunological dysfunction associated with SARS-CoV-2 persistence in immunocompromised patients
· 2026 · Related
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
· Cristiano Alessandri · 2004 · 186 citations · Cited by this paper
Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis
· Leendert Adrianus Trouw · 2017 · 164 citations · Cited by this paper
Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the ‘AMC-Senshu’ method
· Jing Shi · 2012 · 91 citations · Cited by this paper
American College of Rheumatology/ EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision
· Paul Studenic · 2022 · 84 citations · Cited by this paper
Role of Extracellular Vesicles in Autoimmune Pathogenesis
· Wencheng Wu · 2020 · 72 citations · Cited by this paper
Update on the role of extracellular vesicles in rheumatoid arthritis
· Hai-bing Miao · 2022 · 40 citations · Cited by this paper
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
· Ahmad A Sherbini · 2022 · 36 citations · Cited by this paper
Regulatory B cells in rheumatoid arthritis: Alterations in patients receiving anti-TNF therapy
· Zsuzsanna Bankó · 2017 · 30 citations · Cited by this paper
The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
· Myrthe A. M. van Delft · 2017 · 30 citations · Cited by this paper
The Role of Autophagy as a Trigger of Post-Translational Modifications of Proteins and Extracellular Vesicles in the Pathogenesis of Rheumatoid Arthritis
· Gloria Riitano · 2023 · 28 citations · Cited by this paper
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis
· Tsutomu TOGASHI · 2025 · 28 citations · Cited by this paper
Extracellular vesicles: immunomodulation, diagnosis, and promising therapeutic roles for rheumatoid arthritis
· Desalegn Abebaw · 2024 · 25 citations · Cited by this paper
Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with rheumatoid arthritis
· Federica Maria Ucci · 2022 · 23 citations · Cited by this paper
On the origin of rheumatoid factors: Insights from analyses of variable region sequences
· Willem J.J. Falkenburg · 2018 · 20 citations · Cited by this paper
Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis
· Shuichiro Nakabo · 2018 · 14 citations · Cited by this paper
Synovial Fluid Markers and Extracellular Vesicles in Rheumatoid Arthritis
· Veronika Smolinská · 2024 · 13 citations · Cited by this paper
Extracellular microvesicles from patients with Rheumatoid arthritis promote dendritic cell activation in vitro
· Brigitta Buttari · 2025 · 12 citations · Cited by this paper
Untitled · Cited by this paper
Source: OpenAlex (CC0)